Nirmatrelvir and Bedaquiline: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Bedaquiline
Nirmatrelvir
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Increased bedaquiline exposure
Interaction Deep Dive
The concomitant use of bedaquiline (a CYP3A4 substrate) with a potent CYP3A4 inhibitor such as nirmatrelvir/ritonavir may increase bedaquiline exposure. Avoid concurrent use of bedaquiline with nirmatrelvir/ritonavir for more than 14 consecutive days, unless the benefits of the drug combination outweigh the risks. If coadministration is required, use caution and monitor the patient closely for bedaquiline-related adverse effects1.
Why it happens (mechanism)
Inhibition of CYP3A4-mediated metabolism of bedaquiline
Common questions
Can I take Nirmatrelvir and Bedaquiline together?
Increased bedaquiline exposure Always confirm with your pharmacist or prescriber before making any change.
How serious is the Nirmatrelvir and Bedaquiline interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Nirmatrelvir or Bedaquiline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Pfizer Inc: Fact sheet for healthcare providers: Emergency Use Authorization for PAXLOVID(TM). US Food & Drug Administration (FDA). Silver Spring, MD. 2021.
Keep reading about Bedaquiline
Keep reading about Nirmatrelvir
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist